12, Acta Pharmaceutica Sinica B
In this context, suppression of myofibroblast differentiation could be an effective therapeutic approach to prevent excessive cardiac fibrosis
Now, I feel like I'm beating this drum over and over, but after menopause, the risk of heart disease rises
A meal that felt normal before starting medication now feels like Thanksgiving dinner
Regeneron Pharmaceuticals Sector: Muscle-preserving antibody combinations and GLP-1 therapy for obesity HQ: Tarrytown, NY Year Founded: 1988 Origin Story: Founded in 1988 by Leonard Schleifer, MD, PhD, a neurologist and assistant professor at Cornell University Medical College on the premise that drug discovery could be industrialized through proprietary antibody-generation technology
The results were reassuring: survey-reported weight loss closely tracked with medical records, and medication histories aligned well across both sources